White Paper: Looking Ahead: Ophthalmology Clinical Trial Landscape in 2023

Looking ahead at the ophthalmology clinical trial landscape in 2021.

White Paper: Looking Ahead: Ophthalmology Clinical Trial Landscape in 2023

Over 2.2 billion people worldwide are estimated to be visually impaired or blind resulting in a global economic burden of approximately US$269 billion, annually. In the U.S., approximately 12 million people aged 40 years and above have vision impairment and the associated economic impact of major vision problems for this group is US$145 billion, annually. Fueled by research in ophthalmology, eye diseases such as cataracts and AMD, previously thought to be irreversible, now have treatment options that can cure or alleviate symptoms.

This white paper will cover:

  • Growth in demand for ophthalmology CRO services
  • Growth in the ophthalmic therapeutic drugs market
  • Ophthalmology research trends

Connect with us.

Interested in receiving a proposal from Vial? Leave us a message and some of your contact info and we’ll be in touch with you shortly.

Name(Required)
By submitting, you are agreeing to our terms and privacy policy
This field is for validation purposes and should be left unchanged.